Novel enzymatic and immunological responses to oligonucleotides
- 31 December 1995
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 82-83, 431-434
- https://doi.org/10.1016/0378-4274(95)03573-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Modified oligonucleotides as therapeutic and diagnostic agentsCurrent Opinion in Biotechnology, 1995
- Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administrationBiochemical Pharmacology, 1995
- In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in ratsBiochemical Pharmacology, 1995
- Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*Clinical Pharmacology & Therapeutics, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Study of antisense oligonucleotide phosphorothioates containing segments of oligodeoxynucleotides and 2′-o- methyloligoribonucleotidesBioorganic & Medicinal Chemistry Letters, 1994
- Complement Activation and Hemodynamic Changes Following Intravenous Administration of Phosphorothioate Oligonucleotides in the MonkeyAntisense Research and Development, 1994
- Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activityNucleic Acids Research, 1993
- GEM* 91—An Antisense Oligonucleotide Phosphorothioate as a Therapeutic Agent for AIDSAntisense Research and Development, 1992